Products

What will AGI do for Azabuperone?

This classification denotes an antipsychotic agent with the molecular formula C17H23FN2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 9P043590EX chemically known as 4'-fluoro-4-(hexahydropyrrolo(1,2-a)pyrazin-2(1h)-yl)butyrophenone but generally known as azabuperone, which bears US NIH Compound Identifier 18484. European Medicines Agency schedules Azabuperone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05623MIG. The term AZABUPERONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, no. 10 1976, list 16. ). Most nations schedule azabuperone under HS 29335995 and SITC 51576. As of Q4 2014, AZABUPERONE remains the US FDA Preferred Term for this commodity. Azabuperone bears US NLM identifiers UMLS ID C0052743 and NCI Concept Code C73282. SMILES: FC1CCC(C(=O)CCCN2CC3N(CCC3)CC2)CC1.

How AGI delivers it

Four ways AGI delivers for Azabuperone

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Azabuperone, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Azabuperone, get the professional outcome delivered as software, priced on results, not headcount.